Evidence map›Paper›PMID 39201605›Full record

ArticleInternational journal of molecular sciences2024

Enhancing Selectivity and Inhibitory Effects of Chemotherapy Drugs Against Myelogenous Leukemia Cells with

Wendy Lorena Quintero-García, Denerieth Ximena Espinel-Mesa, Erika Marcela Moreno, Elena Stashenko, Ana Cecilia Mesa-Arango, Liliana Torcoroma García

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Wendy Lorena Quintero-GarcíaCorporación Académica Ciencias Básicas Biomédicas, Universidad de Antioquia, Medellín 050010, Colombia.ORCID 0000-0003-0781-697X
Denerieth Ximena Espinel-MesaCorporación Académica Ciencias Básicas Biomédicas, Universidad de Antioquia, Medellín 050010, Colombia.
Erika Marcela MorenoFacultad de Ciencias Médicas y de la Salud, Departamento de Postgrado en Enfermedades Infecciosas, Universidad de Santander, Bucaramanga 680006, Colombia.ORCID 0000-0002-5102-7540
Elena StashenkoNational Research Center for the Agroindustrialization of Aromatic and Medicinal Tropical Species (CENIVAM), Universidad Industrial de Santander, Bucaramanga 680002, Colombia.ORCID 0000-0001-7052-932X
Ana Cecilia Mesa-ArangoCorporación Académica Ciencias Básicas Biomédicas, Universidad de Antioquia, Medellín 050010, Colombia.
Liliana Torcoroma GarcíaFacultad de Ciencias Médicas y de la Salud, Departamento de Postgrado en Enfermedades Infecciosas, Universidad de Santander, Bucaramanga 680006, Colombia.ORCID 0000-0001-9054-9328

Funding

Ministry of Science, Technology, and Innovation, the Ministry of Education, the Ministry of In-dustry, Commerce and Tourism, and ICETEX, Programme Ecosistema Científico - Colombia Científica, from the Francisco José de Caldas Fund RC-FP44842-212-2018
6 · The paper itself

Abstract

Acute myelogenous leukemia (AML) is one of the most lethal cancers, lacking a definitive curative therapy due to essential constraints related to the toxicity and efficacy of conventional treatments. This study explores the co-adjuvant potential of

Indexed as

Acyclic MonoterpenesLippiaOils, VolatileAntineoplastic AgentsApoptosisCell Line, TumorCell ProliferationClofarabineCytarabineDrug SynergismHumansLeukemia, Myeloid, AcuteOxidative StressAcyclic MonoterpenesAntineoplastic AgentscitralClofarabineCytarabineOils, Volatileacute myelogenous leukemiachemotherapycitralLippia alba

Identifiers

PMID39201605
PMCPMC11355005

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.